Company / R&D Expense
Microbot Medical Inc. R&D Expense History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$19.4M
FY2015
5-year range
$14.7M / $21.0M
FY2011-FY2015
Trend
+31.9%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense returned to growth in FY2015 after 2 years of decline, reaching $19M.
Based on SEC 10-K filings.
$19M in FY2015 with a 3-year CAGR of -2.7%.
Declined from $20M to $19M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -2.7%, indicating a declining trend.
- In FY2015, r&d expense increased 31.9% year-over-year.
- Peak r&d expense was recorded in FY2012.
- Lowest r&d expense in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $19.4M | +31.9% |
| FY2014 | $14.7M | -26.4% |
| FY2013 | $19.9M | -5.1% |
| FY2012 | $21.0M | +5.5% |
| FY2011 | $19.9M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026